Skip to main content
Top
Published in: International Urology and Nephrology 1/2013

01-02-2013 | Urology - Original Paper

Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis

Authors: Abdol-Mohammad Kajbafzadeh, Ali Tourchi, Zahra Aryan

Published in: International Urology and Nephrology | Issue 1/2013

Login to get access

Abstract

Purpose

To identify independent factors that may predict vesicoureteral reflux (VUR) resolution after endoscopic treatment using dextranomer/hyaluronic acid copolymer (Deflux®) in children free of anatomical anomalies.

Materials and methods

A retrospective study was conducted in our pediatric referral center from 1998 to 2011 on children with primary VUR who underwent endoscopic injection of Deflux® with or without concomitant autologous blood injection (called HABIT or HIT, respectively). Children with secondary VUR or incomplete records were excluded from the study. Potential factors were divided into three categories including preoperative, intraoperative and postoperative. Success was defined as no sign of VUR on postoperative voiding cystourethrogram. Univariate and multivariate logistic regression models were constructed to identify independent factors that may predict success. Odds ratio (OR) and 95 % confidence interval (95 % CI) for prediction of success were estimated for each factor.

Results

From 485 children received Deflux® injection, a total of 372 with a mean age of 3.10 years (ranged from 6 months to 12 years) were included in the study and endoscopic management was successful in 322 (86.6 %) of them. Of the patients, 185 (49.7 %) underwent HIT and 187 (50.3 %) underwent HABIT technique. On univariate analysis, VUR grade from preoperative category (OR = 4.79, 95 % CI = 2.22–10.30, p = 0.000), operation technique (OR = 0.33, 95 % CI = 0.17–0.64, p = 0.001) and presence of mound on postoperative sonography (OR = 0.06, 95 % CI = 0.02–0.16, p = 0.000) were associated with success. On multivariate analysis, preoperative VUR grade (OR = 4.85, 95 % CI = 2.49–8.96, p = 0.000) and identification of mound on postoperative sonography (OR = 0.07, 95 % CI = 0.01–0.18, p = 0.000) remained as independent success predictors.

Conclusion

Based on this study, successful VUR correction after the endoscopic injection of Deflux® can be predicted with respect to preoperative VUR grade and presence of mound after operation.
Literature
1.
go back to reference Jacobson SH, Hansson S, Jakobsson B (1999) Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr Suppl 88(431):22–30PubMedCrossRef Jacobson SH, Hansson S, Jakobsson B (1999) Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr Suppl 88(431):22–30PubMedCrossRef
2.
go back to reference Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, Khoury AE, Lorenzo AJ, Pohl HG, Shapiro E, Snodgrass WT, Diaz M (2010) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184(3):1134–1144. doi:10.1016/j.juro.2010.05.065 PubMedCrossRef Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, Khoury AE, Lorenzo AJ, Pohl HG, Shapiro E, Snodgrass WT, Diaz M (2010) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184(3):1134–1144. doi:10.​1016/​j.​juro.​2010.​05.​065 PubMedCrossRef
4.
go back to reference Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R, Kirsch A, Koyle MA, Pope J, Shapiro E (2006) Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175(2):716–722. doi:10.1016/S0022-5347(05)00210-7 PubMedCrossRef Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R, Kirsch A, Koyle MA, Pope J, Shapiro E (2006) Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175(2):716–722. doi:10.​1016/​S0022-5347(05)00210-7 PubMedCrossRef
7.
go back to reference Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Mobius TE (1985) International system of radiographic grading of vesicoureteric reflux. International Reflux Study in children. Pediatr Radiol 15(2):105–109PubMedCrossRef Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Mobius TE (1985) International system of radiographic grading of vesicoureteric reflux. International Reflux Study in children. Pediatr Radiol 15(2):105–109PubMedCrossRef
8.
go back to reference O’Donnell B, Puri P (1984) Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 289(6436):7–9CrossRef O’Donnell B, Puri P (1984) Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 289(6436):7–9CrossRef
11.
go back to reference Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ (2011) Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesico-ureteral reflux. J Pediatr Urol. doi:10.1016/j.jpurol.2011.07.006 Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ (2011) Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesico-ureteral reflux. J Pediatr Urol. doi:10.​1016/​j.​jpurol.​2011.​07.​006
12.
go back to reference Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of a 125 iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158(5):1937–1941PubMedCrossRef Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of a 125 iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158(5):1937–1941PubMedCrossRef
17.
go back to reference Dave S, Lorenzo AJ, Khoury AE, Braga LH, Skeldon SJ, Suoub M, Farhat W, Pippi Salle JL, Bagli DJ (2008) Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. J Urol 180(4 Suppl):1594–1599; discussion 1599–1600. doi:10.1016/j.juro.2008.03.084 Dave S, Lorenzo AJ, Khoury AE, Braga LH, Skeldon SJ, Suoub M, Farhat W, Pippi Salle JL, Bagli DJ (2008) Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. J Urol 180(4 Suppl):1594–1599; discussion 1599–1600. doi:10.​1016/​j.​juro.​2008.​03.​084
18.
go back to reference Lorenzo AJ, Pippi Salle JL, Barroso U, Cook A, Grober E, Wallis MC, Bagli DJ, Khoury AE (2006) What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 176(4 Pt 2):1851–1855. doi:10.1016/S0022-5347(06)00599-4 PubMedCrossRef Lorenzo AJ, Pippi Salle JL, Barroso U, Cook A, Grober E, Wallis MC, Bagli DJ, Khoury AE (2006) What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 176(4 Pt 2):1851–1855. doi:10.​1016/​S0022-5347(06)00599-4 PubMedCrossRef
19.
go back to reference Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E (2006) Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176 (4 Pt 2):1856–1859; discussion 1859–1860. doi:10.1016/j.juro.2006.03.124 Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E (2006) Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176 (4 Pt 2):1856–1859; discussion 1859–1860. doi:10.​1016/​j.​juro.​2006.​03.​124
20.
go back to reference Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA (2007) Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol 178(4 Pt 2):1702–1705; discussion 1705–1706. doi:10.1016/j.juro.2007.03.174 Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA (2007) Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol 178(4 Pt 2):1702–1705; discussion 1705–1706. doi:10.​1016/​j.​juro.​2007.​03.​174
25.
go back to reference Lackgren G, Skoldenberg E, Stenberg A (2007) Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 177(3):1124–1128; discussion 1128–1129. doi:10.1016/j.juro.2006.10.094 Lackgren G, Skoldenberg E, Stenberg A (2007) Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 177(3):1124–1128; discussion 1128–1129. doi:10.​1016/​j.​juro.​2006.​10.​094
29.
go back to reference Ben-Meir D, Morgenstern S, Sivan B, Efrat R, Livne PM (2012) Histology proved malpositioning of dextranomer/hyaluronic Acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. J Urol 188(1):258–261. doi:10.1016/j.juro.2012.03.019 PubMedCrossRef Ben-Meir D, Morgenstern S, Sivan B, Efrat R, Livne PM (2012) Histology proved malpositioning of dextranomer/hyaluronic Acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. J Urol 188(1):258–261. doi:10.​1016/​j.​juro.​2012.​03.​019 PubMedCrossRef
Metadata
Title
Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis
Authors
Abdol-Mohammad Kajbafzadeh
Ali Tourchi
Zahra Aryan
Publication date
01-02-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0327-5

Other articles of this Issue 1/2013

International Urology and Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.